INNV
Overvalued by 189.3% based on the discounted cash flow analysis.
Market cap | $426.02 Million |
---|---|
Enterprise Value | $426.55 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.16 |
Beta | 0.41 |
Outstanding Shares | 135,439,668 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -16.58 |
---|---|
PEG | 31.78 |
Price to Sales | 0.73 |
Price to Book Ratio | 1.82 |
Enterprise Value to Revenue | 0.54 |
Enterprise Value to EBIT | -28.47 |
Enterprise Value to Net Income | -27 |
Total Debt to Enterprise | 0.11 |
Debt to Equity | 0.18 |
No data
No data
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors. Its mission is to enable seniors to age independently in their own homes for as long as possible. Its patient-centered care model meaningfully improves...